Research progress in metabolic and receptor-like nuclear imaging agents for hepatocellular carcinoma

VernacularTitle:肝癌的代谢类和受体类核医学显像剂研究进展
Author: Yanli LI ¹ ; Guobing LIU ; Dengfeng CHENG ; Hongcheng SHI
Author Information

1. 复旦大学附属中山医院核医学科上海市影像医学研究所
Keywords: Positron-emission tomography; Carcinoma,hepatocellular; Radiotracer
From: Chinese Journal of Hepatology 2016;24(8):619-623
CountryChina
Language:Chinese
Abstract: Hepatocellular carcinoma (HCC) commonly presents with high morbidity and mortality,and early staging diagnosis and timely treatment is pivotal to prolonging patients' survival time.Compared with traditional morphological imaging methods such as ultrasound,computed tomography (CT),and magnetic resonance imaging (MRI),functional imaging methods like single-photon emission computed tomography (SPECT) and positron emission tomography (PET) are playing an increasingly important role in the early diagnosis,efficacy assessment,prognostic evaluation,and treatment planning for HCC,thanks to their higher sensitivity at a molecular level by using various radiopharmaceuticals.